Levin Capital Strategies’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.09M | Buy |
6,291
+138
| +2% | +$74.9K | 0.23% | 87 |
|
|
2025
Q4 | $3.57M | Hold |
6,153
| – | – | 0.31% | 61 |
|
|
2025
Q3 | $2.98M | Sell |
6,153
-34
| -0.5% | -$15.8K | 0.27% | 62 |
|
|
2025
Q2 | $2.51M | Hold |
6,187
| – | – | 0.24% | 66 |
|
|
2025
Q1 | $3.08M | Hold |
6,187
| – | – | 0.33% | 62 |
|
|
2024
Q4 | $3.22M | Sell |
6,187
-18
| -0.3% | -$9.9K | 0.3% | 61 |
|
|
2024
Q3 | $3.84M | Sell |
6,205
-27
| -0.4% | -$16K | 0.37% | 55 |
|
|
2024
Q2 | $3.45M | Sell |
6,232
-41
| -0.7% | -$23.5K | 0.36% | 54 |
|
|
2024
Q1 | $3.65M | Sell |
6,273
-220
| -3% | -$123K | 0.36% | 55 |
|
|
2023
Q4 | $3.45M | Hold |
6,493
| – | – | 0.37% | 52 |
|
|
2023
Q3 | $3.29M | Sell |
6,493
-420
| -6% | -$224K | 0.39% | 50 |
|
|
2023
Q2 | $3.61M | Sell |
6,913
-116
| -2% | -$62.6K | 0.41% | 49 |
|
|
2023
Q1 | $4.05M | Sell |
7,029
-130
| -2% | -$73.3K | 0.5% | 45 |
|
|
2022
Q4 | $3.94M | Sell |
7,159
-23
| -0.3% | -$12.2K | 0.53% | 45 |
|
|
2022
Q3 | $3.64M | Buy |
7,182
+292
| +4% | +$163K | 0.49% | 46 |
|
|
2022
Q2 | $3.74M | Sell |
6,890
-6,412
| -48% | -$3.53M | 0.44% | 52 |
|
|
2022
Q1 | $7.86M | Sell |
13,302
-3,193
| -19% | -$1.83M | 0.76% | 42 |
|
|
2021
Q4 | $11M | Sell |
16,495
-320
| -2% | -$200K | 1.03% | 33 |
|
|
2021
Q3 | $9.61M | Sell |
16,815
-244
| -1% | -$134K | 0.96% | 34 |
|
|
2021
Q2 | $8.61M | Sell |
17,059
-2,711
| -14% | -$1.28M | 0.88% | 34 |
|
|
2021
Q1 | $9.02M | Sell |
19,770
-5,733
| -22% | -$2.74M | 0.96% | 27 |
|
|
2020
Q4 | $11.9M | Sell |
25,503
-1,088
| -4% | -$510K | 1.33% | 24 |
|
|
2020
Q3 | $11.7M | Sell |
26,591
-134
| -0.5% | -$55.4K | 1.54% | 23 |
|
|
2020
Q2 | $9.68M | Sell |
26,725
-13,595
| -34% | -$4.56M | 1.33% | 26 |
|
|
2020
Q1 | $11.4M | Sell |
40,320
-1,630
| -4% | -$514K | 1.85% | 18 |
|
|
2019
Q4 | $13.6M | Sell |
41,950
-206
| -0.5% | -$62.5K | 1.36% | 27 |
|
|
2019
Q3 | $12.3M | Sell |
42,156
-4,336
| -9% | -$1.24M | 1.36% | 26 |
|
|
2019
Q2 | $13.7M | Sell |
46,492
-125
| -0.3% | -$34.4K | 1.35% | 27 |
|
|
2019
Q1 | $12.8M | Sell |
46,617
-1,571
| -3% | -$391K | 1.43% | 24 |
|
|
2018
Q4 | $10.8M | Sell |
48,188
-1,228
| -2% | -$288K | 0.24% | 58 |
|
|
2018
Q3 | $12.1M | Sell |
49,416
-230
| -0.5% | -$52.9K | 0.21% | 57 |
|
|
2018
Q2 | $10.3M | Sell |
49,646
-2,225
| -4% | -$472K | 0.18% | 61 |
|
|
2018
Q1 | $10.7M | Sell |
51,871
-5,260
| -9% | -$1.1M | 0.19% | 59 |
|
|
2017
Q4 | $10.8M | Sell |
57,131
-1,685
| -3% | -$323K | 0.18% | 60 |
|
|
2017
Q3 | $11.1M | Sell |
58,816
-2,977
| -5% | -$539K | 0.19% | 64 |
|
|
2017
Q2 | $10.8M | Sell |
61,793
-680
| -1% | -$114K | 0.19% | 64 |
|
|
2017
Q1 | $9.6M | Sell |
62,473
-669,521
| -91% | -$102M | 0.17% | 65 |
|
|
2016
Q4 | $103M | Buy |
731,994
+670,206
| +1,085% | +$98.8M | 1.77% | 20 |
|
|
2016
Q3 | $9.83K | Sell |
61,788
-1,436
| -2% | -$221K | 0.14% | 81 |
|
|
2016
Q2 | $9.34M | Sell |
63,224
-2,770
| -4% | -$409K | 0.17% | 78 |
|
|
2016
Q1 | $9.34M | Sell |
65,994
-2,955
| -4% | -$396K | 0.17% | 80 |
|
|
2015
Q4 | $9.78M | Sell |
68,949
-390
| -0.6% | -$52K | 0.17% | 84 |
|
|
2015
Q3 | $8.48M | Sell |
69,339
-5,613
| -7% | -$731K | 0.14% | 96 |
|
|
2015
Q2 | $9.73M | Buy |
74,952
+700
| +0.9% | +$91.3K | 0.14% | 99 |
|
|
2015
Q1 | $9.97M | Sell |
74,252
-290
| -0.4% | -$37.4K | 0.15% | 97 |
|
|
2014
Q4 | $9.34M | Sell |
74,542
-4,438
| -6% | -$540K | 0.14% | 105 |
|
|
2014
Q3 | $9.61M | Sell |
78,980
-14,625
| -16% | -$1.78M | 0.15% | 100 |
|
|
2014
Q2 | $11M | Buy |
93,605
+2,670
| +3% | +$314K | 0.17% | 101 |
|
|
2014
Q1 | $10.9M | Sell |
90,935
-825
| -0.9% | -$98.1K | 0.18% | 85 |
|
|
2013
Q4 | $10.2M | Sell |
91,760
-670
| -0.7% | -$66.6K | 0.16% | 101 |
|
|
2013
Q3 | $8.52M | Sell |
92,430
-3,045
| -3% | -$275K | 0.15% | 104 |
|
|
2013
Q2 | $8.08M | Buy |
+95,475
| New | +$7.95M | 0.15% | 98 |
|
Other funds holding TMO
VCM
Levin Capital Strategies's TMO Position: Q1 2026 in Review
Levin Capital Strategies increased its Thermo Fisher Scientific (TMO) stake by 2.2% in Q1 2026, buying an estimated $74.9K and bringing the position to 6,291 shares worth $3.09M. The position accounts for 0.23% of the portfolio, ranked #87.
Levin Capital Strategies first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $103M in Q4 2016. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Levin Capital Strategies held 6,291 shares of Thermo Fisher Scientific worth $3.09M as of Q1 2026.
- Levin Capital Strategies bought 138 Thermo Fisher Scientific shares in Q1 2026, an estimated $74.9K.
- Thermo Fisher Scientific made up 0.23% of Levin Capital Strategies's portfolio in Q1 2026, its #87 holding.
- Levin Capital Strategies first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- Levin Capital Strategies's Thermo Fisher Scientific position peaked at $103M in Q4 2016.
- 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Levin Capital Strategies's 13F filing for Q1 2026, filed 13 May 2026.